Download
GOEG_Bericht_Preisvergleich_Arzneispezialitäten_brief_report_2018.pdf 603,71KB
WeightNameValue
1000 Titel
  • Price comparison of high-cost medicines ..., 2017
1000 Unterreihe
  • Brief report
1000 Verantwortlich
  • authors: Peter Schneider, Sabine Vogler, Nina Zimmermann, Martin Zuba ; project assistent: Ingrid Freiberger, Monika Schintlmeiste ; commissioned by the Federal Ministry of Labour, Social Affairs, Health and Consumer Protection
  • owner, editor und publisher: Gesundheit Österreich GmbH (Austrian Public Health Institute)
1000 Beteiligung
Gesundheit Österreich GmbH. Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz (Im Auftrag von) |
Gesundheit Österreich GmbH. Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz (Herausgeber/in) |
1000 Autor/in
  1. Schneider, Peter |
  2. Vogler, Sabine |
  3. Zimmermann, Nina |
  4. Zuba, Martin |
  5. Freiberger, Ingrid |
  6. Schintlmeister, Monika |
  7. Gesundheit Österreich GmbH |
  8. Gesundheit Österreich GmbH |
1000 Katalog Id
  • HT019963002
1000 Erscheinungsort Vienna
1000 Verlag Gesundheit Österreich GmbH
1000 Erscheinungsjahr 2018
1000 Erschienen in Price comparison of high-cost medicines ... , 2017
1000 Art der Datei
1000 Publikationstyp
  1. Monografie |
1000 FRL-Sammlung
1000 Sprache der Publikation
1000 Abstract/Summary
  • AIM: The study aims to analyse Austrian prices of high-cost medicines in comparison to other European Union (EU) Member States. METHODS: Medicine price data of all 28 EU Member States were collected through the Pharma Price Information (PPI) service maintained by the Austrian Public Health Institute. Data were surveyed as of September 2017. The survey included 100 high-cost medicines in Austria that were selected based on information about top-selling medicines provided by the Main Association of Austrian Social Security Institutions (outpatient sector) and the Board of the Austrian Association of Hospital Pharmacists (inpatient sector). Ex-factory prices were analysed for all 100 selected medicines. In addition, analyses of further price types (pharmacy purchasing price and pharmacy retail price) were performed for the 60 outpatient medicines surveyed. RESULTS: At the ex-factory price level, price data were available for 82 percent and 69 percent of all surveyed medicines administered in the outpatient and inpatient sector, respectively, in the 27 analysed countries (Malta was excluded due to insufficient data availability). Compared to the other EU Member States, 80 percent of Austrian ex-factory prices of surveyed medicines were above the median. Overall, they were 4.4 percent above the average of the EU Member States, however differences between the two sectors were observed (0.5% above the EU average in the outpatient sector and 10.3% above the EU average in the inpatient sector). Austrian ex-factory prices were the lowest for a few of the analysed high-cost medicines in the outpatient sector, whereas they were never the lowest in the inpatient sector. (...)
1000 Sacherschließung
pharmaceutical pricing
international price comparison
Austria
medicine price
ddc 330 Wirtschaft
ddc 610 Medizin und Gesundheit
ddc 615 Pharmakologie und Therapeutik
1000 DOI 10.4126/FRL01-006413679 |
1000 Dateien
  1. Preisvergleich ausgabenstarker Arzneispezialitäten, 2017: Brief report
1000 Umfang
  • 1 Online-Ressource (IX, 16 Seiten)
1000 Formschlagwörter
1000 Objektart monograph
1000 Beschrieben durch
1000 @id frl:6413679.rdf
1000 Erstellt am 2019-04-01T15:23:16.424+0200
1000 Erstellt von 25
1000 beschreibt frl:6413679
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Fri Apr 26 05:05:41 CEST 2019
1000 Objekt bearb. Mon Apr 01 15:29:09 CEST 2019
1000 ähnlich zu
1000 Vgl. frl:6413679
1000 Oai Id
  1. oai:frl.publisso.de:frl:6413679 |
1000 Identisch zu
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Beschrieben durch
1000 Download
1000 Bestand
1000 Lobid

View source